Silvant Capital Management LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 shares during the period. Silvant […]